MIGB-therapy for David and other medications - $39 416 USD
David is 7 y.o. and he was diagnosed with neuroblastoma last August.
Starting from March David has been receiving MIGB-therapy, thanks to you.
Radioactive Iodine is an important part of this type of treatment. In most cases, neuroblastoma cells are capable of accumulating this radioisotope. And it turns out that these cells are, as it were, irradiated "from the inside", while the rest of the body suffers relatively little. After a few days, most of the radioactive isotope decays or is excreted from the body, and you can proceed to other stages of treatment. And our donors helped to get Iodine for both treatments.
Victor with acute myeloid leukemia needed Xospata, antitumor drug, and we were able to provide it.
“The efficiency of Xospata was studied in a clinical trial of 138 patients with relapsed or refractory AML having a confirmed FLT3 mutation. Twenty-one percent of patients achieved complete remission (no evidence of disease and full recovery of blood counts) or complete remission with partial hematologic recovery (no evidence of disease and partial recovery of blood counts) with treatment. Of the 106 patients who required red blood cell or platelet transfusions at the start of treatment with Xospata, 31 percent became transfusion-free for at least 56 days.” - says FDA.
Also you helped Alina to get Idarubicin and Ixoten.
